Figure 1.
Gprc5c expression levels regulate the development of leukemia. (A) Overall survival according to GPRC5C expression in the Leucegene cohort. High expression levels of GPRC5C (GPRC5C high: ≥75th percentile, red curve) compared with low expression levels (GPRC5C low: <75th percentile, blue curve) are displayed by Kaplan-Meier curves. The P-value was obtained using the log-rank test for the comparison of survival curves. (B) Blue box: schematic representation of the experimental design to overexpress and assess the impact of increased Gprc5c levels in MLL-AF9. Red box: schematic representation of the experimental design to evaluate the effect of the loss of Gprc5c in MLL-AF9. (C) Survival curve depicting AML penetrance upon the gain of Gprc5c in MLL-AF9; n = 9. (D) Survival curve depicting AML penetrance upon loss of Gprc5c in MLL-AF9. Combination of 2 independent experiments; n = 5 to 7. (E) Limiting dilution assays for MLL-AF9-WT and MLL-AF9-Gprc5c-KO. Combination of 2 independent experiments. All represented by mean ± standard deviation. (C-D) Mantel-Cox test, ∗P < .05; ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P <.0001. For all experiments, at least 2 independent experiments were performed. ns, not significant.

Gprc5c expression levels regulate the development of leukemia. (A) Overall survival according to GPRC5C expression in the Leucegene cohort. High expression levels of GPRC5C (GPRC5C high: ≥75th percentile, red curve) compared with low expression levels (GPRC5C low: <75th percentile, blue curve) are displayed by Kaplan-Meier curves. The P-value was obtained using the log-rank test for the comparison of survival curves. (B) Blue box: schematic representation of the experimental design to overexpress and assess the impact of increased Gprc5c levels in MLL-AF9. Red box: schematic representation of the experimental design to evaluate the effect of the loss of Gprc5c in MLL-AF9. (C) Survival curve depicting AML penetrance upon the gain of Gprc5c in MLL-AF9; n = 9. (D) Survival curve depicting AML penetrance upon loss of Gprc5c in MLL-AF9. Combination of 2 independent experiments; n = 5 to 7. (E) Limiting dilution assays for MLL-AF9-WT and MLL-AF9-Gprc5c-KO. Combination of 2 independent experiments. All represented by mean ± standard deviation. (C-D) Mantel-Cox test, ∗P < .05; ∗∗P < .01; ∗∗∗P < .001; ∗∗∗∗P <.0001. For all experiments, at least 2 independent experiments were performed. ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal